title: Striking follicular eruption to pegylated liposomal doxorubicin.
abstract: The adverse effects of pegylated liposomal doxorubicin are primarily cutaneous. The majority of these cutaneous side effects manifest as palmar-plantar erythrodysesthesia, whereas few reports of other cutaneous reactions exist in the literature. The authors report a case of an exuberant follicular eruption in a patient treated with pegylated liposomal doxorubicin. This case also highlights the potential mechanism underlying this unusual histological and clinical reaction.
authors.affiliation: Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia, PA.
authors.forename: Julia
authors.initials: J
authors.lastname: Dai
authors.forename: Robert
authors.initials: R
authors.lastname: Micheletti
authors.forename: Misha
authors.initials: M
authors.lastname: Rosenbach
authors.forename: Emily Y
authors.initials: EY
authors.lastname: Chu
mesh_terms: D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects*; D018284:Cystadenocarcinoma, Serous / Q000188:drug therapy; D004317:Doxorubicin / Q000009:adverse effects / Q000031:analogs & derivatives*; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology*; D005260:Female; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D010051:Ovarian Neoplasms / Q000188:drug therapy; D011092:Polyethylene Glycols / Q000009:adverse effects
chemical_list: D000903:Antibiotics, Antineoplastic; C506643:liposomal doxorubicin; D011092:Polyethylene Glycols; D004317:Doxorubicin